State Street SPDR Bloomberg High Yield Bond ETF vs NeoGenomics Inc. Common Stock — how do they compare? State Street SPDR Bloomberg High Yield Bond ETF trades at $92.27 (market cap $5.70B), while NeoGenomics Inc. Common Stock trades at $17.17 (market cap $2.14B). The key difference: State Street SPDR Bloomberg High Yield Bond ETF is far larger — about 2.7× NeoGenomics Inc. Common Stock's market cap, and NeoGenomics Inc. Common Stock is trading nearer its 52-week high, State Street SPDR Bloomberg High Yield Bond ETF nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold State Street SPDR Bloomberg High Yield Bond ETF for 63 Days and NeoGenomics Inc. Common Stock for 0 Days on average.
| JNK | NEO | |
|---|---|---|
Market Cap | $5.70B | $2.14B |
Volume | 1,722,684 | 2,228,400 |
Sector | Fixed Income | Health |
52-Week High | $98.02 | $19.91 |
52-Week Low | $92.25 | $7.19 |
Typical Hold Time | 63 Days | 0 Days |
Enterprise Value | — | $2.44B |
Signals from Pluang's Aura AI — not financial advice
JNK trades at $92.66, down 0.29% amid a bearish technical outlook with selling pressure across moving averages and oscillators. The ETF shows consistent dividend payments of $0.53 but lacks fundamental ratio data. Recent market focus centers on rising bond yields and geopolitical tensions affecting high-yield bond markets.
Outlook remains cautious as technical indicators signal bearish momentum with RSI at overbought levels. Investment opportunities include steady dividend income, while risks involve sensitivity to interest rate hikes and broader bond market volatility. The ETF's performance is closely tied to credit market conditions.
No Aura AI signal available yet.
Trailing returns across standard periods
What Pluang investors did over the last 30 days
No sentiment data available yet.
Latest headlines on both assets
JNK is a major ETF tracking the Bloomberg High Yield Very Liquid Index. It provides exposure to U.S. dollar-denominated junk bonds with above-average liquidity, featuring 2026 top holdings like EchoStar, Cloud Software Group, and Carnival Corp.
Read more on JNK →NeoGenomics, Inc. is a US cancer diagnostics company that provides genomic and pathology testing services, offering an oncology-focused testing menu used by oncologists, pathologists, and hospital systems across the cancer care continuum.
Read more on NEO →